Brief: Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
30/06/2026 13:49
BRIEF-Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding June 30 (Reuters) - Plus Therapeutics Inc PSTV.O:
PLUS THERAPEUTICS PROVIDES MID-YEAR BUSINESS UPDATE INCLUDING CORPORATE REBRANDING
PLUS THERAPEUTICS - TO BECOME CERENOME, NASDAQ TICKER TO CNSY EFFECTIVE AUGUST 3, 2026
PLUS THERAPEUTICS - AFFIRMS 2026 GUIDANCE ON KEY MILESTONES INCLUDING CNSIDE DIAGNOSTICS
Source text: ID:nGNX9VJQd1
Further company coverage: PSTV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerenome
See all newsBrief: Cerenome Secures In-Network Agreement With Florida Blue For Cnside® Csf Tumor Cell Enumeration And Molecular Profile Tests
Plus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Cerenome Secures In-Network Agreement With Health Care Service Corporation
Plus Therapeutics Inc expected to post a loss of 91 cents a share - Earnings Preview
Brief: Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual For CNSide Cerebrospinal Fluid Assay For Metastatic CNS Cancer